Pomalidomide-based maintenance post-autologous hematopoietic cell transplantation in multiple myeloma: a case series

Ann Hematol. 2019 Oct;98(10):2457-2459. doi: 10.1007/s00277-019-03772-1. Epub 2019 Aug 7.

Authors

Tahani Atieh¹, Anne Hubben², Beth Faiman³, Jason Valent³, Christy Joy Samaras³, Jack Khouri³

Affiliations

¹ Department of Internal Medicine, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH, 44195, USA. atieht@ccf.org.
² Department of Internal Medicine, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH, 44195, USA.
³ Multiple Myeloma Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.

PMID: 31392460
DOI: 10.1007/s00277-019-03772-1

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Female
Hematopoietic Stem Cell Transplantation*
Humans
Maintenance Chemotherapy*
Male
Middle Aged
Multiple Myeloma / therapy*
Retrospective Studies
Thalidomide / administration & dosage
Thalidomide / analogs & derivatives*
Transplantation, Autologous

Substances

Thalidomide
pomalidomide